Development and validation of a novel competing risk model for predicting survival of esophagogastric junction adenocarcinoma: a SEER population-based study and external validation

BACKGROUND: Adenocarcinoma in Esophagogastric Junction (AEG) is a severe gastrointestinal malignancy with a unique clinicopathological feature. Hence, we aimed to develop a competing risk nomogram for predicting survival for AEG patients and compared it with new 8th traditional tumor-node-metastasis...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tongbo, Wu, Yan, Zhou, Hong, Wu, Chaorui, Zhang, Xiaojie, Chen, Yingtai, Zhao, Dongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836166/
https://www.ncbi.nlm.nih.gov/pubmed/33499821
http://dx.doi.org/10.1186/s12876-021-01618-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836166/
https://www.ncbi.nlm.nih.gov/pubmed/33499821
http://dx.doi.org/10.1186/s12876-021-01618-7

Ejemplares similares